RodrÃguez, M.D.C.R.;                     RodrÃguez, I.G.;                     Nattress, C.;                     Qureshi, A.;                     Halldén, G.    
        HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses 2022, 14, 1006.
    https://doi.org/10.3390/v14051006
    AMA Style
    
                                RodrÃguez MDCR,                                 RodrÃguez IG,                                 Nattress C,                                 Qureshi A,                                 Halldén G.        
                HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses. 2022; 14(5):1006.
        https://doi.org/10.3390/v14051006
    
    Chicago/Turabian Style
    
                                RodrÃguez, MarÃa Del Carmen RodrÃguez,                                 Inés GarcÃa RodrÃguez,                                 Callum Nattress,                                 Ahad Qureshi,                                 and Gunnel Halldén.        
                2022. "HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models" Viruses 14, no. 5: 1006.
        https://doi.org/10.3390/v14051006
    
    APA Style
    
                                RodrÃguez, M. D. C. R.,                                 RodrÃguez, I. G.,                                 Nattress, C.,                                 Qureshi, A.,                                 & Halldén, G.        
        
        (2022). HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses, 14(5), 1006.
        https://doi.org/10.3390/v14051006